INTRODUCTION
Complex regional pain syndrome (CRPS) is characterized by pain and sensory, autonomic, trophic, and motor abnormalities [1] . Patients with CRPS often complain of extreme pain even with minor irritation or tooth extraction under local anesthesia. If dental treatment under local anesthesia is not possible, general anesthesia may be considered. CRPS is rarely encountered in the dental office, and only a few studies report dental treatment of patients with CRPS. Patients with CRPS experience pain and anxiety, making dental treatment challenging, even under general anesthesia.
Herein, we report a case of severe pain during dental treatment caused by mechanical stimulation in a patient with CRPS, which did not disappear after the treatment under general anesthesia but was relieved through intravenous sedation with ketamine. General anesthesia was induced four times for multiple tooth caries treatment. Twelve teeth (#15, #22, #23, #25, #26, #34, #35, #36, #37, #44, #45, and #46) were restored with resin. Endodontic treatment was performed for three teeth (#31, #32, #47), and one tooth (#24) was extracted.
In the operating room, intravenous access was established with a 22-gauge cannula on the left arm. to the bed with a restraining band (Fig. 1) . After 55 min of dental treatment, the total intravenous anesthesia was terminated. To restore spontaneous breathing, 0.8 mg of The patient was transferred to the recovery room. She complained of extreme pain in the right toe that was injured before the operation but not in the dental treatment area. According to the medical report, the patient had been treated for CRPS with intravenous sedation, using dexmedetomidine (0.5~1 µg/kg/h infusion in 45 min) and propofol (1.0~3.0 µg/ml TCI in 1 h) to reduce pain and recover safely. The patient was moderately sedated. One hour after the first sedation, toe pain still persisted after the patient restored consciousness, and she had no improvement in symptoms that were present before the sedation. For repeat sedation, 5 mg of midazolam and 100 mg of ketamine were used. After 1 h, her consciousness restored. After the second sedation, the pain had persisted, but she felt better than before, and the consciousness level was clear (Fig. 2) . Subsequently, she was discharged normally. After 5 h, she sustained an injury in the toe but did not complain of toe pain at the next visit. Medications such as non-steroidal anti-inflammatory Persisting pain, which is disproportionate to the inciting event Must report at least one symptom from three of the following four categories:
-Sensory: hyperalgesia and/or allodynia -Vasomotor: temperature asymmetry, skin color changes, and/or skin color asymmetry -Sudomotor/edema: edema, sweating changes, and/or sweating asymmetry -Motor/trophic: decreased range of motion, motor dysfunction (weakness, tremor, dystonia), and/or trophic changes (hair, nails, skin) Must present with at least one sign at the time of evaluation from two or more of the following categories:
-Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch, deep somatic pressure, and/or joint movement) -Vasomotor: evidence of temperature asymmetry, skin color changes, and/or asymmetry -Sudomotor/edema: evidence of edema, sweating changes, and/or sweating asymmetry -Motor/trophic: evidence of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), and/or trophic changes (hair, nails, skin) There are no other diagnostic criteria that better explain the signs and symptoms.
-A sign is counted only if it is observed at the time of diagnosis.
-The recommended research criteria for complex regional pain syndrome are more specific but less sensitive than the clinical criteria: They require the presence of symptoms from four different categories and signs from two different categories. small-fiber neuropathy, sensitivity to neuropeptides, psychological stress, genetics, and auto-immune disorders [10] . Although infection is considered the primary pathophysiological mechanism, other factors can also be considered.
The diagnostic criteria called the Budapest criteria has high specificity and sensitivity compared to IASP (Table   1 ). However, there are no definitive diagnostic tools, such as laboratory tests or radiographic assessments. Osteopenia and patchy osteoporosis, which can be detected on three-phase bone scans, can be seen in the early stage.
Sweat testing, diagnostic sympathetic blocks, and quantitative sensory testing can be useful for the examination of CRPS. The important treatment strategies are: 1)
patient education for self-management (Table 2) Dexmedetomidine is an α2-adrenergic receptor agonist, which was initially approved as a sedative agent for use in the intensive care unit. In recent studies, intraoperative dexmedetomidine infusion caused a significant reduction in the need for both intraoperative and postoperative analgesics [14] . In several reports, the effects of dexmedetomidine on the treatment of acute pain in CRPS are also favorable [15] . Most studies reported a combination with ketamine or other analgesics while some studies reported administration of dexmedetomidine alone for acute pain.
Dexmedetomidine has a short elimination half-life, and its analgesic effect is unclear compared to its sedation effect. Dexmedetomidine may not have been effective for the present patient.
We presented a rare case of dental treatment of a patient with CRPS under general anesthesia and reported management of pain that was not associated with the treatment area. The patient was diagnosed with type 1 CRPS and underwent various treatments, including morphine-pump implantation. The pain developed from a minor injury before the induction of general anesthesia and persisted for 4 h. Remifentanil (potent ultra-shortacting opioid), propofol (short-acting intravenous general anesthetic), and dexmedetomidine (highly selective α 2-adrenergic receptor agonist, sedatives) were used, but the pain did not reduce. Ketamine used for the second sedation provided pain reduction, and the patient was discharged through the normal pathway.
